AR111211A1 - Composiciones inmunoestimulantes y sus usos - Google Patents

Composiciones inmunoestimulantes y sus usos

Info

Publication number
AR111211A1
AR111211A1 ARP180100280A ARP180100280A AR111211A1 AR 111211 A1 AR111211 A1 AR 111211A1 AR P180100280 A ARP180100280 A AR P180100280A AR P180100280 A ARP180100280 A AR P180100280A AR 111211 A1 AR111211 A1 AR 111211A1
Authority
AR
Argentina
Prior art keywords
compositions
stimulating compositions
immuno stimulating
polypeptides
immuno
Prior art date
Application number
ARP180100280A
Other languages
English (en)
Original Assignee
Australian Meat & Live Stock
Us Agriculture
The State Of Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017900358A external-priority patent/AU2017900358A0/en
Application filed by Australian Meat & Live Stock, Us Agriculture, The State Of Queensland filed Critical Australian Meat & Live Stock
Publication of AR111211A1 publication Critical patent/AR111211A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

La presente se relaciona con polipéptidos inmunogénicos, fragmentos inmunogénicos de estos y composiciones que los comprenden, para usar para provocar una respuesta inmunitaria en un sujeto frente a una garrapata. También proporciona métodos para usar dichas composiciones y polipéptidos. Molécula de unión al antígeno.
ARP180100280A 2017-02-06 2018-02-06 Composiciones inmunoestimulantes y sus usos AR111211A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2017900358A AU2017900358A0 (en) 2017-02-06 Immunostimulating Compositions and Uses Therefor

Publications (1)

Publication Number Publication Date
AR111211A1 true AR111211A1 (es) 2019-06-19

Family

ID=63039295

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180100280A AR111211A1 (es) 2017-02-06 2018-02-06 Composiciones inmunoestimulantes y sus usos

Country Status (7)

Country Link
US (1) US11623945B2 (es)
AR (1) AR111211A1 (es)
AU (1) AU2018214451B2 (es)
BR (1) BR112019016143A2 (es)
MX (1) MX2019009359A (es)
WO (1) WO2018141029A1 (es)
ZA (1) ZA201905875B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019153029A1 (en) 2018-02-06 2019-08-15 Meat & Livestock Australia Limited Polypeptide, compositions and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5196321A (en) 1986-10-02 1993-03-23 Massachusetts Institute Of Technology Methods for in vitro cleavage of ubiquitin fusion proteins
IL84574A (en) 1986-11-27 1994-10-07 Biotech Australia Pty Ltd Beef tick antigen, its parts, homologous vapitopios with similar immune activity, process for their preparation, polynucleotide encoding them, vaccines containing them, antibodies derived from
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
DE768377T1 (de) 1988-09-02 1998-01-02 Dyax Corp Herstellung und Auswahl von Rekombinantproteinen mit verschiedenen Bindestellen
DK0585287T3 (da) 1990-07-10 2000-04-17 Cambridge Antibody Tech Fremgangsmåde til fremstilling af specifikke bindingsparelementer
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
ES2113940T3 (es) 1990-12-03 1998-05-16 Genentech Inc Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas.
DE69233697T2 (de) 1991-03-01 2008-01-24 Dyax Corp., Cambridge Verfahren zur Entwicklung von bindenden Mikroproteinen
US5759552A (en) 1991-03-07 1998-06-02 Virogenetics Corporation Marek's disease virus recombinant poxvirus vaccine
DE69233750D1 (de) 1991-04-10 2009-01-02 Scripps Research Inst Bibliotheken heterodimerer Rezeptoren mittels Phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US5837821A (en) 1992-11-04 1998-11-17 City Of Hope Antibody construct
ATE187494T1 (de) 1992-12-11 1999-12-15 Dow Chemical Co Multivalente einkettige antikörper
WO1995004827A1 (en) 1993-08-10 1995-02-16 Biotech Australia Pty. Ltd. Tick antigen
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
EP0859841B1 (en) 1995-08-18 2002-06-19 MorphoSys AG Protein/(poly)peptide libraries
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
EP1278551A2 (en) 2000-04-21 2003-01-29 Vical Incorporated Compositions and methods for (in vivo) delivery of polynucleotide-based therapeutics
US6783761B2 (en) 2000-05-05 2004-08-31 Aphton Corporation Chimeric peptide immunogens
EP2322202A3 (en) 2002-10-29 2011-07-27 Genentech, Inc. Compositions and methods for the treatment of immune diseases
CU23919B1 (es) 2010-09-28 2013-07-31 Ct De Ingeniería Genética Y Biotecnología Composición vacunal para el control de las infestaciones por ectoparásitos
US9205144B2 (en) 2011-06-03 2015-12-08 Dana-Farber Cancer Institute, Inc. Identification of conserved peptide blocks in homologous polypeptides
US8722063B2 (en) 2012-05-24 2014-05-13 The United States Of America, As Represented By The Secretary Of Agriculture Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission
AU2013295770A1 (en) 2012-07-27 2015-01-29 Zoetis Services Llc Tick toxin compositions
WO2014159052A1 (en) * 2013-03-13 2014-10-02 The United States Of America, As Represented By The Secretary Of Agriculture Vaccination of companion animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission
RU2677347C2 (ru) 2013-03-29 2019-01-16 Интервет Интернэшнл Б.В. Вакцина против клещей рода rhipicephalus
WO2019153029A1 (en) 2018-02-06 2019-08-15 Meat & Livestock Australia Limited Polypeptide, compositions and uses thereof

Also Published As

Publication number Publication date
AU2018214451A1 (en) 2019-09-26
WO2018141029A1 (en) 2018-08-09
US20200062810A1 (en) 2020-02-27
ZA201905875B (en) 2024-01-31
BR112019016143A2 (pt) 2020-04-07
US11623945B2 (en) 2023-04-11
AU2018214451B2 (en) 2022-02-03
MX2019009359A (es) 2020-01-30

Similar Documents

Publication Publication Date Title
CL2021001744A1 (es) Péptidos y combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de próstata y otros tipos de cáncer (divisional de la solicitud no. 201800324)
AR121380A2 (es) Péptidos y combinación de péptidos y andamiajes para su uso en inmunoterapia contra carcinoma de células renales (rcc) y otros cánceres
CL2016000538A1 (es) Compuesto que comprende la proteína globo h y klh, composiciones de una vacuna de hidratos de carbono para la inducción de respuestas inmunes y usos de los mismos
CL2019002939A1 (es) Péptidos y combinación de péptidos para el uso en la inmunoterapia contra el cáncer (divisional solicitud 201801531)
CR20170419A (es) Nuevos péptidos y nueva combinación de péptidos para el uso en la inmunoterapia contra el cáncer de páncreas y otros tipos de cáncer.
CO2018003436A2 (es) Anticuerpos agonistas que se unen específicamente a cd40 humana y métodos de uso
CR20180492A (es) Células t transfectadas y receptores de células t de utilidad en inmunoterapias contra el cáncer
CR20180051A (es) Nuevos epítopos celulares y nuevas combinaciones de epítopos celulares para el uso en la inmunoterapia del mieloma y de otros tipos de cáncer.
CR20180174A (es) Nuevos péptidos, combinaciones de péptidos y soportes para el uso en el tratamiento inmunoterapéutico de varios tipos de cáncer
EA201791150A1 (ru) Новые пептиды и комбинации пептидов для применения в иммунотерапии гепатоклеточной карциномы (гкк) и других видов рака
GT201700131A (es) Composiciones y métodos para anticuerpos dirigidos a bmp6
BR112017008165A2 (pt) anticorpos de domínio único direcionados contra antígenos intracelulares
CL2019000019A1 (es) Anticuerpos con baja inmunogenicidad y uso de los mismos
UY38016A (es) Oligonucleótidos inmunoestimulantes
BR112018073221A2 (pt) métodos de previsão da utilidade de proteínas ou seus fragmentos, métodos de seleção e/ou avaliação de modificações de aminoácidos específicas, método de fornecimento de vacinas e vacina
PH12014501795B1 (en) Rotavirus subunit vaccines and methods of making and use thereof
CL2020002965A1 (es) Anticuerpos anti-cd63, conjugados y usos de estos
CL2019002943A1 (es) Nuevos péptidos y combinación para el uso en la inmunoterapia contra varios tipo de cáncer. divisional solicitud 201801533)
CY1124847T1 (el) Καινοτομα πεπτιδια και συνδυασμος πεπτιδιων για χρηση στην ανοσοθεραπεια εναντι του ηπατοκυτταρικου καρκινωματος (hcc) και αλλων καρκινων
AR111211A1 (es) Composiciones inmunoestimulantes y sus usos
CO2021012294A2 (es) Composiciones de lawsonia intracellularis y métodos de uso de las mismas
IN2014CN00547A (es)
AR095939A1 (es) Vacuna contra garrapatas rhipicephalus
AR110965A1 (es) Polipéptidos, composiciones y sus usos
AR121129A1 (es) Anticuerpos anti-e-selectina, composiciones y métodos de uso